Fractyl Health cuts workforce ~45%, focuses on Revita for post-GLP-1 weight maintenance; co-founder Jay Caplan to retire

Fractyl Health announced a strategic reprioritization to concentrate resources on advancing Revita toward potential FDA marketing authorization for post-GLP-1 weight maintenance, and a workforce reduction of approximately 45% expected to be substantially completed by November 2026. Co-founder, President and Chief Product Officer Jay Caplan will retire from his executive roles effective October 30, 2026.

Detected & updated continuously · Source: Nebula